Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Toi

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Breast Cancer (Tokyo, Japan)|January 16, 2002
Aromatase and aromatase inhibitorsM Toi, H Bando, S Saji
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Detection of epithelial cell death in the body by cytokeratin 18 measurementT Ueno, M Toi, S Linder
Anticancer Research|November 1, 1993
Enhanced inhibition of thymidylate synthase by 5-fluorouracil and [6S]leucovorin combination therapy for breast cancerT Tominaga, M Toi, T Shirasaka
Lancet (London, England)|August 13, 1994
Rapid induction of hepatocyte growth factor by heparinT Taniguchi, M Toi, T Tominaga
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Translational research in oncology comes timelyL W C Chow, M Toi
The Lancet. Oncology|March 21, 2002
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsM Toi, T Matsumoto, H Bando
International Journal of Oncology|June 16, 2001
Clinical significance of plasma nucleosome levels in cancer patientsK Kuroi, C Tanaka, M Toi
Oncology Reports|May 20, 2011
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patientsY Yamamoto, M Toi, T Tominaga
Nihon Geka Gakkai Zasshi|May 1, 1996
[The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer]S Saji, M Toi, T Tominaga
British Journal of Cancer|January 15, 2009
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in JapanM Kondo, S-L Hoshi, M Toi
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Breast Cancer (Tokyo, Japan)|January 16, 2002
Aromatase and aromatase inhibitorsM Toi, H Bando, S Saji
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Detection of epithelial cell death in the body by cytokeratin 18 measurementT Ueno, M Toi, S Linder
Anticancer Research|November 1, 1993
Enhanced inhibition of thymidylate synthase by 5-fluorouracil and [6S]leucovorin combination therapy for breast cancerT Tominaga, M Toi, T Shirasaka
Lancet (London, England)|August 13, 1994
Rapid induction of hepatocyte growth factor by heparinT Taniguchi, M Toi, T Tominaga
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 2, 2006
Translational research in oncology comes timelyL W C Chow, M Toi
The Lancet. Oncology|March 21, 2002
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsM Toi, T Matsumoto, H Bando
International Journal of Oncology|June 16, 2001
Clinical significance of plasma nucleosome levels in cancer patientsK Kuroi, C Tanaka, M Toi
Oncology Reports|May 20, 2011
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patientsY Yamamoto, M Toi, T Tominaga
Nihon Geka Gakkai Zasshi|May 1, 1996
[The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer]S Saji, M Toi, T Tominaga
British Journal of Cancer|January 15, 2009
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in JapanM Kondo, S-L Hoshi, M Toi
Pageof 23